AI assistant
Sending…
Sanara MedTech Inc. — Director's Dealing 2025
Sep 16, 2025
33339_dirs_2025-09-16_930389e6-7326-4b46-9ddd-47045a99d302.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-09-15
Reporting Person: Yon Seth D (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-09-15 | Common Stock | A | 28563 | — | Acquired | 89851 | Direct |
Footnotes
F1: Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on September 15, 2026, 2027 and 2028, respectively, provided that the reporting person is employed by the Issuer through each such date.
More from Sanara MedTech Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 11
Proxy Solicitation & Information Statement
2026
Apr 17
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Major Shareholding Notification
2026
Apr 14
Annual Report
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 23